Biological Safety Testing Products and Services Market
The biological safety testing market encompasses products like reagents and instruments, as well as services used to ensure the safety of pharmaceutical and biological products. Key customers include pharmaceutical companies, researchers, and government agencies involved in the development of new medicines. Market growth is primarily driven by rising innovation in new therapies like cell and gene therapy, increased investment in the healthcare industry, and the enforcement of stringent government safety regulations.
CAGR
12.9%
Compound Annual Growth Rate
Current Value
$7.50B
Estimated 2026
Projected Value
$19.8B
By 2034